Physician profile
Sunitha Malla
NPI 1346534302
$1,764.95
in general payments reported to CMS, 2019-2025
16 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $299 · 2024: $1,124 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,764.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $301.43 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $256.78 | 2023-2025 | Freestyle Libre 3, Jot Dx |
| Astrazeneca Pharmaceuticals Lp | $242.62 | 2024-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $215.30 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $146.75 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $143.70 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.34 | 2023-2024 | Jardiance |
| Dexcom, INC. | $101.05 | 2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $45.97 | 2023-2024 | |
| Astellas Pharma US INC | $38.28 | 2024 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.14 | 2025 | Xifaxan |
| Shield Therapeutics INC | $28.29 | 2024 | |
| Inari Medical, INC. | $25.34 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Scilex Pharmaceuticals INC. | $18.92 | 2024 | |
| Medtronic, INC. | $14.89 | 2024 | Intellis Adaptivestim |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $14.15 | 2025 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunitha Malla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.